+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Wet Age-Related Macular Degeneration Market and Competitive Landscape - 2020

  • ID: 5023477
  • Report
  • April 2020
  • Region: Global
  • Fore Pharma
1 of 2
The research report Global Wet Age-Related Macular Degeneration Market and Competitive Landscape - 2020, provides comprehensive insights into the Wet Age-Related Macular Degeneration pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Wet Age-Related Macular Degeneration market size and drug sales. It also provides insights into Wet Age-Related Macular Degeneration epidemiology and late stage pipeline.

This research covers the following: Wet Age-Related Macular Degeneration treatment options, Wet Age-Related Macular Degeneration late stage clinical trials pipeline, Wet Age-Related Macular Degeneration prevalence by countries, Wet Age-Related Macular Degeneration market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Wet Age-Related Macular Degeneration pipeline: Find out drugs in clinical trials for the treatment of Wet Age-Related Macular Degeneration by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Wet Age-Related Macular Degeneration epidemiology: Find out the number of patients diagnosed (prevalence) with Wet Age-Related Macular Degeneration by countries
  • Wet Age-Related Macular Degeneration drugs: Identify key drugs marketed and prescribed for Wet Age-Related Macular Degeneration in the US, including trade name, molecule name, and company
  • Wet Age-Related Macular Degeneration drugs sales: Find out the sales value for Wet Age-Related Macular Degeneration drugs by countries
  • Wet Age-Related Macular Degeneration market valuations: Find out the market size for Wet Age-Related Macular Degeneration drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Wet Age-Related Macular Degeneration drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Wet Age-Related Macular Degeneration drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Wet Age-Related Macular Degeneration market
  • Develop in-depth knowledge of competition and markets
  • Analyze Wet Age-Related Macular Degeneration drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Wet Age-Related Macular Degeneration market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Wet Age-Related Macular Degeneration Treatment Options

2. Wet Age-Related Macular Degeneration Pipeline Insights
2.1. Wet Age-Related Macular Degeneration Phase 3 Clinical Trials
2.2. Wet Age-Related Macular Degeneration Phase 2 Clinical Trials
2.3. Wet Age-Related Macular Degeneration Phase 1 Clinical Trials

3. Wet Age-Related Macular Degeneration Epidemiology Analysis by Countries

4. US Wet Age-Related Macular Degeneration Market Insights
4.1. Marketed Drugs for Wet Age-Related Macular Degeneration in US
4.2. US Wet Age-Related Macular Degeneration Market Size & Forecast
4.3. US Wet Age-Related Macular Degeneration Drugs Sales & Forecast
4.4. US Wet Age-Related Macular Degeneration Market Share Analysis

5. Germany Wet Age-Related Macular Degeneration Market Insights
5.1. Marketed Drugs for Wet Age-Related Macular Degeneration in Germany
5.2. Germany Wet Age-Related Macular Degeneration Market Size & Forecast
5.3. Germany Wet Age-Related Macular Degeneration Drugs Sales Forecast
5.4. Germany Wet Age-Related Macular Degeneration Market Share Analysis

6. France Wet Age-Related Macular Degeneration Market Insights
6.1. Marketed Drugs for Wet Age-Related Macular Degeneration in France
6.2. France Wet Age-Related Macular Degeneration Market Size & Forecast
6.3. France Wet Age-Related Macular Degeneration Product Sales Forecast
6.4. France Wet Age-Related Macular Degeneration Market Share Analysis

7. Italy Wet Age-Related Macular Degeneration Market Insights
7.1. Marketed Drugs for Wet Age-Related Macular Degeneration in Italy
7.2. Italy Wet Age-Related Macular Degeneration Market Size & Forecast
7.3. Italy Wet Age-Related Macular Degeneration Product Sales Forecast
7.4. Italy Wet Age-Related Macular Degeneration Market Share Analysis

8. Spain Wet Age-Related Macular Degeneration Market Insights
8.1. Marketed Drugs for Wet Age-Related Macular Degeneration in Spain
8.2. Spain Wet Age-Related Macular Degeneration Market Size & Forecast
8.3. Spain Wet Age-Related Macular Degeneration Product Sales Forecast
8.4. Spain Wet Age-Related Macular Degeneration Market Share Analysis

9. UK Wet Age-Related Macular Degeneration Market Insights
9.1. Marketed Drugs for Wet Age-Related Macular Degeneration in UK
9.2. UK Wet Age-Related Macular Degeneration Market Size & Forecast
9.3. UK Wet Age-Related Macular Degeneration Product Sales Forecast
9.4. UK Wet Age-Related Macular Degeneration Market Share Analysis

10. Europe Wet Age-Related Macular Degeneration Market Insights
10.1. Europe Wet Age-Related Macular Degeneration Market Size & Forecast
10.2. Europe Wet Age-Related Macular Degeneration Product Sales Forecast
10.3. Europe Wet Age-Related Macular Degeneration Market Share Analysis

11. Japan Wet Age-Related Macular Degeneration Market Insights
11.1. Marketed Drugs for Wet Age-Related Macular Degeneration in Japan
11.2. Japan Wet Age-Related Macular Degeneration Market Size & Forecast
11.3. Japan Wet Age-Related Macular Degeneration Product Sales Forecast
11.4. Japan Wet Age-Related Macular Degeneration Market Share Analysis

12. Global Wet Age-Related Macular Degeneration Market Insights
12.1. Global Wet Age-Related Macular Degeneration Market Size & Forecast
12.2. Global Wet Age-Related Macular Degeneration Product Sales Forecast
12.3. Global Wet Age-Related Macular Degeneration Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Wet Age-Related Macular Degeneration Phase 3 Clinical Trials, Global, 2020
Table 2: Wet Age-Related Macular Degeneration Phase 2 Clinical Trials, Global, 2020
Table 3: Wet Age-Related Macular Degeneration Phase 1 Clinical Trials, Global, 2020
Table 4: Wet Age-Related Macular Degeneration Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Wet Age-Related Macular Degeneration in US, 2019
Table 6: US Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 7: US Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 8: US Wet Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Wet Age-Related Macular Degeneration in Germany, 2019
Table 10: Germany Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 11: Germany Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 12: Germany Wet Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Wet Age-Related Macular Degeneration in France, 2019
Table 14: France Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 15: France Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 16: France Wet Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Wet Age-Related Macular Degeneration in Italy, 2019
Table 18: Italy Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 19: Italy Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 20: Italy Wet Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Wet Age-Related Macular Degeneration in Spain, 2019
Table 22: Spain Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 23: Spain Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 24: Spain Wet Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 25: Marketed Drugs for Wet Age-Related Macular Degeneration in UK, 2019
Table 26: UK Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 27: UK Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 28: UK Wet Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 29: Europe Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 30: Europe Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 31: Marketed Drugs for Wet Age-Related Macular Degeneration in Japan, 2019
Table 32: Japan Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 33: Japan Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 34: Japan Wet Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 35: Global Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 36: Global Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Wet Age-Related Macular Degeneration Pipeline by Phase (%), Global, 2020
Figure 2: Wet Age-Related Macular Degeneration Prevalence by Countries, 2016 - 2024
Figure 3: US Wet Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 4: US Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 5: US Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 6: US Wet Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 7: Germany Wet Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 8: Germany Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 9: Germany Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 10: Germany Wet Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 11: France Wet Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 12: France Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 13: France Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 14: France Wet Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 15: Italy Wet Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 16: Italy Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 17: Italy Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 18: Italy Wet Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 19: Spain Wet Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 20: Spain Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 21: Spain Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 22: Spain Wet Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 23: UK Wet Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 24: UK Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 25: UK Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 26: UK Wet Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 27: Europe Wet Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 28: Europe Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 29: Europe Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 30: Europe Wet Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 31: Japan Wet Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 32: Japan Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 33: Japan Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 34: Japan Wet Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 35: Global Wet Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 36: Global Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 37: Global Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 38: Global Wet Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll